Becton, Dickinson and Company (BDX)
(Delayed Data from NYSE)
$176.37 USD
-1.88 (-1.05%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $176.31 -0.06 (-0.03%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
For Becton, Dickinson and Company, the company has a dividend yield of 2.33% compared to the Medical - Dental Supplies industry's median yield of zero percent.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
BDX 176.37 -1.88(-1.05%)
Will BDX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BDX
Earnings Preview: Becton Dickinson (BDX) Q3 Earnings Expected to Decline
Hologic's International Momentum Takes Shape: Will Execution Pay Off?
BDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
BD Partners With Waters to Build High-Volume Diagnostics Leader
How Hologic Leverages Its Financial Firepower to Drive Long-Term Value
Top Stock Reports for Amazon.com, Home Depot & Cisco Systems
Other News for BDX
Earnings week ahead: AMD, PLTR, PFE, DIS, O, ET, SHOP, GILD, MCD, CAT, VTRS, BP, UBER, CGC, and more
BDX Unveils At-Home HPV Test to Revolutionize Cervical Cancer Screening | BDX stock news
BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening ...
BDX Gains FDA Approval for BD Veritor System to Detect COVID-19 Antigens
BD gets FDA nod for rapid COVID-19 test